By a News Reporter-Staff News Editor at Angiogenesis Weekly -- Researchers detail new data in Angiogenesis. According to news reporting originating in Shanghai, People's Republic of China, by NewsRx journalists, research stated, "Angiogenesis is a process that forms new blood capillaries from existing vessels, which is of great physiological and pathological significance. Although recent studies provide evidence that cuprous oxide nanoparticles (CO-NPs) may have biomedical potential, the mechanisms of CO-NPs in angiogenesis have not been investigated to date."
The news reporters obtained a quote from the research from Second Military Medical University, "We have studied the anti-angiogenic properties of CO-NPs on primary human umbilical vein endothelial cells (HUVECs). We found that CO-NPs were able to induce cell morphology changes and suppress cell proliferation, migration and tube formation in vitro and in vivo dose dependently. Furthermore, CO-NPs could induce cell apoptosis both at the early and late apoptotic stage and induce cell cycle arrest at S phase in a dose dependent manner. As signalling via the vascular endothelial growth factor receptor-2 (VEGFR2) is critical for angiogenic responses, we further explored the expression of VEGFR2 after the treatment of CO-NPs. They were found to inhibit VEGFR2 expression dose and time dependently both at the protein and mRNA level while had no effect on VEGF and VEGFR1 expression."
According to the news reporters, the research concluded: "Together, we report for the first time that CO-NPs can act as an anti-angiogenic agent by suppressing VEGFR2 expression, which may be a potential nanomedicine for angiogenesis therapy."
For more information on this research see: Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression. Nanoscale, 2014;6(6):3206-16. (Royal Society of Chemistry - www.rsc.org/; Nanoscale - pubs.rsc.org/en/journals/journalissues/nr)
Our news correspondents report that additional information may be obtained by contacting H. Song, Dept. of Ophthalmology, Changhai Hospital, Second Military Medical University, Shanghai, 200433, People's Republic of China. Additional authors for this research include W. Wang, P. Zhao, Z. Qi and S. Zhao (see also Angiogenesis).
Keywords for this news article include: Asia, Shanghai, Angiogenesis, Nanoparticle, Nanotechnology, Emerging Technologies, People's Republic of China.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC